These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35833114)

  • 21. Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes.
    Chen F; Ma J; Hu S; Wu C; Chen S; Lin J
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):135. PubMed ID: 38682187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
    Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
    EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma.
    Xiao L; Li Q; Huang Y; Fan Z; Ma L; Liu B; Yuan X
    J Healthc Eng; 2022; 2022():7651758. PubMed ID: 35251577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma.
    Liao Y; Wang Y; Cheng M; Huang C; Fan X
    Front Genet; 2020; 11():311. PubMed ID: 32391047
    [No Abstract]   [Full Text] [Related]  

  • 26. Significance of novel PANoptosis genes to predict prognosis and therapy effect in the lung adenocarcinoma.
    Miao Z; Yu W
    Sci Rep; 2024 Sep; 14(1):20934. PubMed ID: 39251701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A methylation-related lncRNA-based prediction model in lung adenocarcinomas.
    Yang K; Liu H; Li JH
    Clin Respir J; 2024 Aug; 18(8):e13753. PubMed ID: 39187946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma.
    Li W; Ou D; Zhang J; Ye M
    Comput Math Methods Med; 2022; 2022():3887857. PubMed ID: 35836921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma.
    Cao X; Ji Y; Li J; Liu Z; Chen C
    Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature.
    Si Y; Zhao Z; Meng X; Zhao K
    Sci Rep; 2024 Oct; 14(1):23243. PubMed ID: 39369095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.
    Xu Z; Chen C
    Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning-based immune prognostic model and ceRNA network construction for lung adenocarcinoma.
    He X; Su Y; Liu P; Chen C; Chen C; Guan H; Lv X; Guo W
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7379-7392. PubMed ID: 36939925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of immune escape-related genes in lung adenocarcinoma.
    Jia HR; Li WC; Wu L
    Transl Cancer Res; 2024 Jun; 13(6):2647-2661. PubMed ID: 38988926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinoma.
    Liu T; Liu J; Chen Q; Wu L; Zhang L; Qiao D; Huang Z; Lu T; Hu A; Wang J
    Medicine (Baltimore); 2024 Sep; 103(38):e39854. PubMed ID: 39312319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma.
    Luo C; Lei M; Zhang Y; Zhang Q; Li L; Lian J; Liu S; Wang L; Pi G; Zhang Y
    J Cell Mol Med; 2020 Jan; 24(2):1233-1244. PubMed ID: 31779055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
    Wu C; Rao X; Lin W
    Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma.
    Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q
    BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The construction and analysis of ceRNA network and patterns of immune infiltration in lung adenocarcinoma.
    Li J; Liu W; Dong X; Dai Y; Chen S; Zhao E; Liu Y; Bao H
    BMC Cancer; 2021 Nov; 21(1):1228. PubMed ID: 34781924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.